Resistance of TNF/L T alpha double deficient mice to bleomycin-induced fibrosis

被引:36
作者
Piguet, PF
Kaufman, S
Barazzone, C
Muller, M
Ryffel, B
Eugster, HP
机构
[1] AMGEN INC,THOUSAND OAKS,CA 91320
[2] INST TOXICOL,CH-8603 ZURICH,SWITZERLAND
[3] UNIV BASEL,DEPT PATHOL,CH-4003 BASEL,SWITZERLAND
关键词
TNF; fibrosis; bleomycin;
D O I
10.1046/j.1365-2613.1997.d01-240.x
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
In order to evaluate the role and mode of action of TNF in bleomycin-induced lung fibrosis, mice deficient for TNF and LT alpha (Delta TNF/LT alpha) were examined at 2 months of age and after 3 weekly i.v. injections of bleomycin. The body weight of the Delta TNF/LT alpha mice was 88 +/- 11% of that of the wild type littermates. Lung collagen, evaluated by its hydroxyproline content, was also lower (81 +/- 9%) in mutant than in wild type littermates. Bleomycin induced a diffuse alveolitis with focal areas of alveolar remodelling in wild type but not in Delta TNF/LT alpha, mice. Lymphoid infiltration was also prominent in wild type, but absent from Delta TNF/LT alpha, mice. Bleomycin injections increased collagen deposition, as evaluated by the lung hydroxyproline content, more markedly in wild type, than in Delta TNF/LT alpha, mice. Cell trapping in the alveolar capillaries was evaluated by semi-quantitative electron microscopy. Bleomycin markedly increased platelet trapping in the alveolar capillaries of wild type, but not of Delta TNF/LT alpha, mice. This study indicates that the expression of TNF/LT alpha genes increases the deposition of collagen in both untreated and inflamed lung and that these genes may act, at least in part, by promoting platelet trapping.
引用
收藏
页码:43 / 48
页数:6
相关论文
共 18 条
[1]   TYPE-BETA TRANSFORMING GROWTH-FACTOR IN HUMAN-PLATELETS - RELEASE DURING PLATELET DEGRANULATION AND ACTION ON VASCULAR SMOOTH-MUSCLE CELLS [J].
ASSOIAN, RK ;
SPORN, MB .
JOURNAL OF CELL BIOLOGY, 1986, 102 (04) :1217-1223
[2]   TUMOR-NECROSIS-FACTOR-ALPHA IS INVOLVED IN MOUSE GROWTH AND LYMPHOID-TISSUE DEVELOPMENT [J].
DEKOSSODO, S ;
GRAU, GE ;
DANEVA, T ;
POINTAIRE, P ;
FOSSATI, L ;
ODY, C ;
ZAPF, J ;
PIGUET, PF ;
GAILLARD, RC ;
VASSALLI, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05) :1259-1264
[3]  
ELIAS H, 1980, AM J ANAT, V159, P412
[4]   Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-alpha double-deficient mice [J].
Eugster, HP ;
Muller, M ;
Karrer, U ;
Car, BD ;
Schnyder, B ;
Eng, VM ;
Woerly, G ;
LeHir, M ;
diPadova, F ;
Aguet, M ;
Zinkernagel, R ;
Bluethmann, H ;
Ryffel, B .
INTERNATIONAL IMMUNOLOGY, 1996, 8 (01) :23-36
[5]  
GALVAN L, 1981, CANCER RES, V41, P5103
[6]   MECHANISMS OF BLEOMYCIN-INDUCED LUNG DAMAGE [J].
HAY, J ;
SHAHZEIDI, S ;
LAURENT, G .
ARCHIVES OF TOXICOLOGY, 1991, 65 (02) :81-94
[7]   MONITORING OF COLLAGEN AND COLLAGEN FRAGMENTS IN CHROMATOGRAPHY OF PROTEIN MIXTURES [J].
HUSZAR, G ;
MAIOCCO, J ;
NAFTOLIN, F .
ANALYTICAL BIOCHEMISTRY, 1980, 105 (02) :424-429
[8]  
KARMIOL S, 1992, CYTOKINES HLTH DISEA, P271
[9]   BLEOMYCIN - A PHARMACOLOGICAL TOOL IN THE STUDY OF THE PATHOGENESIS OF INTERSTITIAL PULMONARY FIBROSIS [J].
LAZO, JS ;
HOYT, DG ;
SEBTI, SM ;
PITT, BR .
PHARMACOLOGY & THERAPEUTICS, 1990, 47 (03) :347-358
[10]   EXPRESSION OF A TUMOR-NECROSIS-FACTOR-ALPHA TRANSGENE IN MURINE LUNG CAUSES LYMPHOCYTIC AND FIBROSING ALVEOLITIS - A MOUSE MODEL OF PROGRESSIVE PULMONARY FIBROSIS [J].
MIYAZAKI, Y ;
ARAKI, K ;
VESIN, C ;
GARCIA, I ;
KAPANCI, Y ;
WHITSETT, JA ;
PIGUET, PF ;
VASSALLI, P .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (01) :250-259